vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and TANDY LEATHER FACTORY INC (TLF). Click either name above to swap in a different company.

TANDY LEATHER FACTORY INC is the larger business by last-quarter revenue ($22.3M vs $14.7M, roughly 1.5× IRIDEX CORP). On growth, TANDY LEATHER FACTORY INC posted the faster year-over-year revenue change (8.7% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs 7.4%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Tandy Leather Factory, Inc. is an American specialty retailer and wholesale distributor of leather and leatherwork related products. It operates more than 100 stores worldwide. Originally part of the Tandy Corporation, Tandy Leather has gone through a series of acquisitions and mergers, eventually being sold to The Leather Factory in 2000. The Tandy Leather flagship store next to their corporate headquarters in Fort Worth, Texas also houses the Al and Ann Stohlman Leathercraft Museum.

IRIX vs TLF — Head-to-Head

Bigger by revenue
TLF
TLF
1.5× larger
TLF
$22.3M
$14.7M
IRIX
Growing faster (revenue YoY)
TLF
TLF
+78.4% gap
TLF
8.7%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
7.4%
TLF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRIX
IRIX
TLF
TLF
Revenue
$14.7M
$22.3M
Net Profit
$-930.0K
Gross Margin
37.2%
54.3%
Operating Margin
-2.8%
Net Margin
-4.2%
Revenue YoY
-69.7%
8.7%
Net Profit YoY
-379.3%
EPS (diluted)
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
TLF
TLF
Q4 25
$14.7M
$22.3M
Q3 25
$12.5M
$17.3M
Q2 25
$13.6M
$17.8M
Q1 25
$11.9M
$19.0M
Q4 24
$12.7M
$20.5M
Q3 24
$11.6M
$17.4M
Q2 24
$12.6M
$17.3M
Q1 24
$11.8M
$19.3M
Net Profit
IRIX
IRIX
TLF
TLF
Q4 25
$-930.0K
Q3 25
$-1.6M
$-1.4M
Q2 25
$-994.0K
$-199.0K
Q1 25
$-1.7M
$11.6M
Q4 24
$-834.0K
$333.0K
Q3 24
$-1.9M
$-132.0K
Q2 24
$-2.7M
$101.0K
Q1 24
$-3.5M
$525.0K
Gross Margin
IRIX
IRIX
TLF
TLF
Q4 25
37.2%
54.3%
Q3 25
32.1%
58.9%
Q2 25
34.5%
59.5%
Q1 25
42.5%
56.3%
Q4 24
44.0%
53.0%
Q3 24
37.3%
57.8%
Q2 24
40.7%
58.0%
Q1 24
37.9%
56.7%
Operating Margin
IRIX
IRIX
TLF
TLF
Q4 25
-2.8%
Q3 25
-11.3%
-3.9%
Q2 25
-6.9%
0.4%
Q1 25
-1.7%
1.4%
Q4 24
-3.9%
0.9%
Q3 24
-16.1%
-1.5%
Q2 24
-20.9%
0.4%
Q1 24
-28.0%
3.4%
Net Margin
IRIX
IRIX
TLF
TLF
Q4 25
-4.2%
Q3 25
-12.6%
-7.8%
Q2 25
-7.3%
-1.1%
Q1 25
-14.2%
60.8%
Q4 24
-6.6%
1.6%
Q3 24
-16.7%
-0.8%
Q2 24
-21.2%
0.6%
Q1 24
-29.5%
2.7%
EPS (diluted)
IRIX
IRIX
TLF
TLF
Q4 25
$-0.18
Q3 25
$-0.09
$-0.17
Q2 25
$-0.06
$-0.02
Q1 25
$-0.10
$1.47
Q4 24
$-0.05
$0.04
Q3 24
$-0.12
$-0.02
Q2 24
$-0.16
$0.01
Q1 24
$-0.21
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
TLF
TLF
Cash + ST InvestmentsLiquidity on hand
$6.0M
$16.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$52.6M
Total Assets
$29.2M
$86.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
TLF
TLF
Q4 25
$6.0M
$16.1M
Q3 25
$5.6M
$12.0M
Q2 25
$6.8M
$16.4M
Q1 25
$7.2M
$23.6M
Q4 24
$2.4M
$13.3M
Q3 24
$3.9M
$10.1M
Q2 24
$4.1M
$11.5M
Q1 24
$5.4M
$12.3M
Total Debt
IRIX
IRIX
TLF
TLF
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
TLF
TLF
Q4 25
$52.6M
Q3 25
$4.7M
$53.4M
Q2 25
$6.1M
$56.1M
Q1 25
$852.0K
$55.8M
Q4 24
$2.1M
$57.2M
Q3 24
$2.6M
$57.6M
Q2 24
$4.2M
$57.5M
Q1 24
$6.5M
$57.2M
Total Assets
IRIX
IRIX
TLF
TLF
Q4 25
$29.2M
$86.6M
Q3 25
$28.4M
$84.5M
Q2 25
$31.6M
$76.5M
Q1 25
$34.2M
$77.9M
Q4 24
$29.1M
$74.9M
Q3 24
$30.2M
$73.0M
Q2 24
$31.2M
$72.8M
Q1 24
$34.1M
$72.4M
Debt / Equity
IRIX
IRIX
TLF
TLF
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
TLF
TLF
Operating Cash FlowLast quarter
$5.0M
Free Cash FlowOCF − Capex
$4.0M
FCF MarginFCF / Revenue
18.1%
Capex IntensityCapex / Revenue
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
TLF
TLF
Q4 25
$5.0M
Q3 25
$-1.2M
$-1.0M
Q2 25
$-397.0K
$-4.0M
Q1 25
$-1.1M
$-536.0K
Q4 24
$-1.2M
$4.5M
Q3 24
$-3.1M
$-535.0K
Q2 24
$-1.3M
$-514.0K
Q1 24
$-1.6M
$1.1M
Free Cash Flow
IRIX
IRIX
TLF
TLF
Q4 25
$4.0M
Q3 25
$-1.2M
$-3.0M
Q2 25
$-410.0K
$-7.3M
Q1 25
$-1.2M
$-1.9M
Q4 24
$-1.2M
$3.8M
Q3 24
$-3.1M
$-1.4M
Q2 24
$-715.0K
Q1 24
$-1.7M
$-141.0K
FCF Margin
IRIX
IRIX
TLF
TLF
Q4 25
18.1%
Q3 25
-9.4%
-17.2%
Q2 25
-3.0%
-41.0%
Q1 25
-9.8%
-9.8%
Q4 24
-9.8%
18.8%
Q3 24
-26.5%
-8.2%
Q2 24
-4.1%
Q1 24
-14.0%
-0.7%
Capex Intensity
IRIX
IRIX
TLF
TLF
Q4 25
4.3%
Q3 25
0.1%
11.2%
Q2 25
0.1%
18.7%
Q1 25
0.1%
7.0%
Q4 24
0.1%
3.3%
Q3 24
0.0%
5.1%
Q2 24
0.0%
1.2%
Q1 24
0.0%
6.4%
Cash Conversion
IRIX
IRIX
TLF
TLF
Q4 25
Q3 25
Q2 25
Q1 25
-0.05×
Q4 24
13.55×
Q3 24
Q2 24
-5.09×
Q1 24
2.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons